Global Allergy Conjunctivitis Market Report 2024

Allergy Conjunctivitis Global Market Report 2023 – By Drug Class (Antihistamines and Mast Cell Stabilizers, Corticosteroids, Other Drug Classes), By Disease Type (Mild, Severe), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Allergy Conjunctivitis Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Allergy conjunctivitis is inflammation of the lining of the eye (conjunctiva) which is caused by an allergic reaction to substances like pollen or mold spores. Conjunctiva is the membrane or tissue that covers the inside of eyelids, as well as the white part of the eyeball. Symptoms of allergic conjunctivitis includes red, itchy, and watery eyes.

The main drug class of allergy conjunctivitis are antihistamines and mast cell stabilizers, corticosteroids, and others. Antihistamine and mast cell stabilizers are prescriptions or over-the-counter medications that inhibit the physiological action of histamines. The diseases involved are mild and severe whose conjunctivitis are distributed through hospital pharmacies, drug stores, and retail pharmacies, and online pharmacies.

The global allergy conjunctivitis market is segmented -

1) By Drug Class: Antihistamines and Mast Cell Stabilizers, Corticosteroids, Other Drug Classes

2) By Disease Type: Mild, Severe

3) By Distribution Channel: Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies

The global allergy conjunctivitis market size is expected to grow from $2.12 billion in 2022 to $2.27 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global allergy conjunctivitis market is expected to grow to $2.93 billion in 2027 at a CAGR of 5.1%.

The rise in exposure to air pollutants and chemicals is expected to boost the growth of the allergy conjunctivitis market going forward. Human eyes, one of the most sensitive parts of the human body, are constantly at risk due to ongoing exposure to the poisons in air pollution. Long-term exposure to airborne pollutants and chemicals causes a variety of eye issues, including allergic conjunctivitis, allergies, burning, watering, blurred vision, redness, itching, and persistent discomfort, requiring treatments. For instance, according to the United States Environmental Protection Agency (EPA), an independent executive agency of the United States federal government tasked with environmental protection matters, in the United States, around 67 million tons of pollutants were released into the atmosphere in 2021. Therefore, the rise in exposure to air pollutants and chemicals is driving the growth of the allergy conjunctivitis market.

Major players in the allergy conjunctivitis market are Allergan plc., Santen Pharmaceutical Co Ltd., Bausch & Lomb Incorporated, Novartis AG, Sun Pharmaceutical Industries Ltd., Ocular Therapeutix Inc., Alcon, Eton Pharmaceutical, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alembic Pharmaceuticals Ltd., Cipla Ltd., Grevis Pharmaceutical Private Limited, Indoco RemediesLtd., Jabs Biotech Pvt. Ltd., JAWA Pharmaceuticals Pvt. Ltd., Auven Therapeutics, and Atopix Therapeutics Ltd.

Product innovation is the key trend gaining popularity in the allergy conjunctivitis market. Major companies operating in the allergy conjunctivitis market are focused on developing innovative and advanced products to strengthen their market position. For instance, in February 2020, Alcon, a US-based medical company specializing in eye care products launched Pataday, the eye allergy drop. The Pataday brand contains the no. 1 doctor-prescribed eye allergy itch relief ingredient and the first once-daily allergy itch relief drop that is available without a prescription. In time for the start of the spring allergy season, Pataday Once Daily Relief and Pataday Twice Daily Relief will be commercially available in the United States. These medications will be sold in all significant mass-market, drug, and grocery stores nationwide (more than 40,000 locations), as well as online. A multimillion-dollar media strategy supporting the launch includes a national TV advertising campaign and a strong web presence to reach people who suffer from eye allergies.

In September 2020, Santen Holdings U.S. Inc., a US-based pharmaceutical company and subsidiary of Santen Pharmaceutical, a Japan-based pharmaceutical company, specializing in ophthalmology, acquired Eyevance Pharmaceuticals LLC for an amount of $225 million. This acquisition enables Santan to expand its global reach and move into the US pharmaceuticals industry. Eyevance Pharmaceuticals LLC is a US-based pharmaceutical company that develops and commercializes topical ophthalmic products targeting the ocular surface and anterior segment.

North America was the largest region in the allergy conjunctivitis market share in 2022. The regions covered in the global allergy conjunctivitis market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergy conjunctivitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The allergy conjunctivitis market consists of sales of therapeutics that are used to treat inflammation of eyes caused due to allergens.  Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The allergy conjunctivitis market research report is one of a series of new reports from The Business Research Company that provides allergy conjunctivitis market statistics, including allergy conjunctivitis industry global market size, regional shares, competitors with allergy conjunctivitis market share, detailed allergy conjunctivitis market segments, market trends, and opportunities, and any further data you may need to thrive in the allergy conjunctivitis industry. This allergy conjunctivitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Allergy Conjunctivitis Market Characteristics

    3. Allergy Conjunctivitis Market Trends And Strategies

    4. Allergy Conjunctivitis Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Allergy Conjunctivitis Market

    4.2. Ukraine-Russia War Impact On Allergy Conjunctivitis Market

    4.3. Impact Of High Inflation On Allergy Conjunctivitis Market

    5. Allergy Conjunctivitis Market Size And Growth

    5.1. Global Allergy Conjunctivitis Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Allergy Conjunctivitis Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Allergy Conjunctivitis Market Segmentation

    6.1. Global Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Antihistamines And Mast Cell Stabilizers

    Corticosteroids

    Other Drug Classes

    6.2. Global Allergy Conjunctivitis Market, Segmentation By Disease Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Mild

    Severe

    6.3. Global Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Drug Stores And Retail Pharmacies

    Online Pharmacies

    7. Allergy Conjunctivitis Market Regional And Country Analysis

    7.1. Global Allergy Conjunctivitis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Allergy Conjunctivitis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Allergy Conjunctivitis Market  

    8.1. Asia-Pacific Allergy Conjunctivitis Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Allergy Conjunctivitis Market  

    9.1. China Allergy Conjunctivitis Market Overview  

    9.2. China Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Allergy Conjunctivitis Market  

    10.1. India Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Allergy Conjunctivitis Market  

    11.1. Japan Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Allergy Conjunctivitis Market  

    12.1. Australia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Allergy Conjunctivitis Market  

    13.1. Indonesia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Allergy Conjunctivitis Market  

    14.1. South Korea Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Allergy Conjunctivitis Market  

    15.1. Western Europe Allergy Conjunctivitis Market Overview

    15.2. Western Europe Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Allergy Conjunctivitis Market  

    16.1. UK Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Allergy Conjunctivitis Market  

    17.1. Germany Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Allergy Conjunctivitis Market  

    18.4. France Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Allergy Conjunctivitis Market  

    19.1. Eastern Europe Allergy Conjunctivitis Market Overview

    19.2. Eastern Europe Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Allergy Conjunctivitis Market  

    20.1. Russia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Allergy Conjunctivitis Market  

    21.1. North America Allergy Conjunctivitis Market Overview

    21.2. North America Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Allergy Conjunctivitis Market  

    22.1. USA Allergy Conjunctivitis Market Overview

    22.2. USA Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Allergy Conjunctivitis Market  

    23.1. South America Allergy Conjunctivitis Market Overview

    23.2. South America Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Allergy Conjunctivitis Market  

    24.1. Brazil Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Allergy Conjunctivitis Market  

    25.1. Middle East Allergy Conjunctivitis Market Overview

    25.2. Middle East Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Allergy Conjunctivitis Market  

    26.1. Africa Allergy Conjunctivitis Market Overview

    26.2. Africa Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Allergy Conjunctivitis Market Competitive Landscape And Company Profiles

    27.1. Allergy Conjunctivitis Market Competitive Landscape

    27.2. Allergy Conjunctivitis Market Company Profiles

    27.2.1. Allergan plc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Santen Pharmaceutical Co Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bausch & Lomb Incorporated

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Novartis AG

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Sun Pharmaceutical Industries Ltd.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Allergy Conjunctivitis Market

    29. Allergy Conjunctivitis Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Allergy Conjunctivitis Market, Segmentation By Disease Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Allergy Conjunctivitis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Allergy Conjunctivitis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Allergan plc. Financial Performance
  • Table 47: Santen Pharmaceutical Co Ltd. Financial Performance
  • Table 48: Bausch & Lomb Incorporated Financial Performance
  • Table 49: Novartis AG Financial Performance
  • Table 50: Sun Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Allergy Conjunctivitis Market, Segmentation By Disease Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Allergy Conjunctivitis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Allergy Conjunctivitis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Allergan plc. Financial Performance
  • Figure 47: Santen Pharmaceutical Co Ltd. Financial Performance
  • Figure 48: Bausch & Lomb Incorporated Financial Performance
  • Figure 49: Novartis AG Financial Performance
  • Figure 50: Sun Pharmaceutical Industries Ltd. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report